|
EP2716167A1
|
|
Non-pharmaceutical composition comprising short chain fatty acids
|
|
EP2698156A1
|
|
Phenylbutyric acid for chemoprevention
|
|
EP2698155A1
|
|
Pharmaceutical unit dosage form comprising 4-phenylbutyric acid
|
|
EP2607367A1
|
|
Glycerol phenyl butyrate derivatives
|
|
EP2599767A1
|
|
Phenylbutyl-derivatives
|
|
EP2607366A1
|
|
Glycerol phenyl butyrate esters
|
|
EP2599479A1
|
|
4-phenylbutyric acid for the treatment of alzheimer's disease
|
|
EP2599481A1
|
|
4-phenylbutyric acid for the treatment or prevention of various diseases
|
|
EP2599482A1
|
|
Low dose therapeutic use of glyceryl tri-(4-phenylbutyrate)
|
|
EP2599477A1
|
|
4-Phenylbutyric acid sustained release formulation
|
|
EP2599483A1
|
|
4-Phenylbutyric acid formulation
|
|
EP2599474A1
|
|
4-phenylbutyric acid for cosmetic use
|
|
EP2589388A1
|
|
Use of a Teichoic acid for the treatment of malignant ascites
|
|
EP2589387A1
|
|
Use of a teichoic acid for the treatment of malignant liquor cerebrospinalis in the brain
|
|
EP2574237A1
|
|
Use of a lipoteichoic acid, mono- or polyglycerophosphate for antibacterial pre-treatment and especially in medical devices
|
|
EP2545911A1
|
|
Use of Lipoteichoic Acid in the Treatment of Non-Encapsulated Cancer Cells
|
|
EP2545909A1
|
|
Combination of D-Amino Acids and Lipoteichoic Acid
|
|
EP2545910A1
|
|
Use of Lipoteichoic Acid in the treatment of cancer in an inflammatory state
|
|
EP2397458A1
|
|
Organic salts and co-crystals of phenylbutyric acid
|
|
EP2389932A1
|
|
Compositions for use in genetic disorders comprising 4-phenyl-butyric acid and its salts
|
